InvestorsHub Logo
Followers 0
Posts 580
Boards Moderated 0
Alias Born 06/21/2005

Re: None

Thursday, 03/02/2006 8:18:10 PM

Thursday, March 02, 2006 8:18:10 PM

Post# of 30387
Just a note to all board members. Remember during the interview, Dr. Moro said he plans to keep certain therapy applications of the technology, as opposed to licensing them out. It is my guess that this quite possibly would eventually become the largest revenue generator of them all. Imagine all people known to have cancer, using recaf based therapy, potentially the most effective & efficient means of targeting and killing cancerous cells. Below is an article I cut & pasted regarding the most popular form of treatment for cancer, chemo-therapy! Next, is an excerpt from an article Half full posted (from the bottom of post-2332) regarding in-vitro experiments in targeting cancerous cells.

It's not a stretch to envision recaf based therapy, easily overtaking chemotherapy as the #1 therapy for cancer!

Conventional cancer treatments such as chemotherapy and radiation therapy can injure and kill these tumor cells, but with an inevitable degree of collateral damage. By way of example, chemotherapy has a therapeutic index of six to one, meaning that one healthy cell is killed for every six cancer cells which are destroyed. Given that tumors can be made up of millions of cells, the incidental damage caused by chemotherapy is considerable. Radiation therapy has the same drawback.
http://www.damninteresting.com/?p=378

Anti-RECAF antibodies or AFP itself can also be used for targeting cancer cells with radioactivity for tumor
imaging and with mercurial compounds to selectively kill cancer cells. In-vitro experiments show 100% killing
in a variety of cancers with 5-15% death of normal cells.


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.